Head-to-head comparison of prostate-specific membrane antigen PET and multiparametric MRI in the diagnosis of pretreatment patients with prostate cancer: a meta …
J Ma, Q Yang, X Ye, W Xu, Y Chang, R Chen… - European …, 2024 - Springer
Objectives To compare prostate-specific membrane antigen (PSMA) PET with
multiparametric MRI (mpMRI) in the diagnosis of pretreatment prostate cancer (PCa) …
multiparametric MRI (mpMRI) in the diagnosis of pretreatment prostate cancer (PCa) …
Up-to-date imaging and diagnostic techniques for prostate cancer: A literature review
M Zhu, Z Liang, T Feng, Z Mai, S Jin, L Wu, H Zhou… - Diagnostics, 2023 - mdpi.com
Prostate cancer (PCa) faces great challenges in early diagnosis, which often leads not only
to unnecessary, invasive procedures, but to over-diagnosis and treatment as well, thus …
to unnecessary, invasive procedures, but to over-diagnosis and treatment as well, thus …
Complex implementation factors demonstrated when evaluating cost-effectiveness and monitoring racial disparities associated with [18F]DCFPyL PET/CT in prostate …
K Subramanian, J Martinez… - Scientific Reports, 2023 - nature.com
Prostate cancer (PC) staging with conventional imaging often includes multiparametric
magnetic resonance (MR) of the prostate, computed tomography (CT) of the chest …
magnetic resonance (MR) of the prostate, computed tomography (CT) of the chest …
Long-Term Outcomes of Prostate-Specific Membrane Antigen–PET Imaging of Recurrent Prostate Cancer
N Kunst, JB Long, S Westvold, PC Sprenkle… - JAMA network …, 2024 - jamanetwork.com
Importance Although prostate-specific membrane antigen positron emission tomography
(PSMA-PET) has shown improved sensitivity and specificity compared with conventional …
(PSMA-PET) has shown improved sensitivity and specificity compared with conventional …
Bone scintigraphy versus PSMA-targeted PET/CT or PET/MRI in prostate cancer: lessons learned from recent systematic reviews and meta-analyses
F Dondi, D Albano, F Bertagna, G Treglia - Cancers, 2022 - mdpi.com
Positron emission tomography (PET) combined with computed tomography (PET/CT) or
magnetic resonance imaging (PET/MRI) using several radiopharmaceuticals—particularly …
magnetic resonance imaging (PET/MRI) using several radiopharmaceuticals—particularly …
PSMA PET/CT for response assessment and overall survival prediction in patients with metastatic castration-resistant prostate cancer treated with androgen receptor …
QA Shagera, I Karfis, P Kristanto… - Journal of Nuclear …, 2023 - Soc Nuclear Med
We aimed to evaluate the role of prostate-specific membrane antigen (PSMA) PET/CT for
response assessment and outcome prediction in patients with metastatic castration-resistant …
response assessment and outcome prediction in patients with metastatic castration-resistant …
Can 68Ga‐PSMA positron emission tomography and multiparametric MRI guide treatment for biochemical recurrence after radical prostatectomy?
Y Khanna, V Chinni, K Gnanasambantham… - BJU …, 2023 - Wiley Online Library
Objective To evaluate the role of multiparametric magnetic resonance imaging (mpMRI) and
Gallium‐68 (68Ga)‐prostate‐specific membrane antigen (PSMA) positron emission …
Gallium‐68 (68Ga)‐prostate‐specific membrane antigen (PSMA) positron emission …
Neural blind deconvolution for deblurring and supersampling PSMA PET
Objective. To simultaneously deblur and supersample prostate specific membrane antigen
(PSMA) positron emission tomography (PET) images using neural blind deconvolution …
(PSMA) positron emission tomography (PET) images using neural blind deconvolution …
Comparison of multiparametric MRI and the combination of PSMA plus MRI for the intraprostatic diagnosis of prostate cancer: a systematic review and meta-analysis
GB Torri, PA Pereira, CP Wiethan… - Clinical Nuclear …, 2024 - journals.lww.com
Clinical Nuclear Medicine Log in or Register Subscribe to journalSubscribe Get new issue
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe …
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe …
Cost-Effectiveness Modeling of Prostate-Specific Membrane Antigen Positron Emission Tomography with Piflufolastat F 18 for the Initial Diagnosis of Patients with …
Background and objectives Piflufolastat F 18 is a novel prostate-specific membrane antigen
(PSMA)-targeted positron emission tomography (PET) radiotracer that is superior to …
(PSMA)-targeted positron emission tomography (PET) radiotracer that is superior to …